AnaptysBio
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AnaptysBio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 67% to $17,157,000. Profit margin reached -954%. Total operating expenses were $181,568,000.
Profit Margin
| 2014 | 15.83M | 3.53M | 22.3% |
|---|---|---|---|
| 2015 | 17.57M | -5.40M | -30.76% |
| 2016 | 16.68M | -4.25M | -25.53% |
| 2017 | 10M | -30.07M | -300.7% |
| 2018 | 5M | -61.65M | -1233.12% |
| 2019 | 8M | -97.33M | -1216.7% |
| 2020 | 75M | -19.92M | -26.56% |
| 2021 | 63.17M | -57.19M | -90.53% |
| 2022 | 10.28M | -128.72M | -1251.33% |
| 2023 | 17.15M | -163.61M | -953.66% |
ANAB Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 17.15M | 10.28M | 63.17M | 75M | 8M | 5M | 10M | 16.68M | 17.57M | 15.83M |
Cost of revenue | 2.37M | 2.33M | 98.49M | 80.02M | 99.33M | 0 | 29.44M | 0 | 17.30M | 8.61M |
Gross profit | 14.78M | 7.95M | -35.32M | -5.02M | -91.33M | 5M | -19.44M | 16.68M | 267K | 7.22M |
Operating exp. | ||||||||||
Research and development | 132.28M | 88.79M | 98.49M | 80.02M | 99.33M | 56.19M | 29.44M | 15.41M | 17.30M | 8.61M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 181.56M | 125.44M | 119.98M | 98.87M | 115.43M | 71.72M | 38.78M | 19.70M | 20.89M | 10.96M |
Operating income | -164.41M | -115.15M | -56.81M | -23.87M | -107.43M | -66.72M | -28.78M | -3.02M | -3.32M | 4.87M |
Other income (expenses), net | 788K | -13.54M | -982K | 3.94M | 9.94M | -159K | -1.28M | -776K | -1.94M | -1.33M |
Income before tax | -163.62M | -128.7M | -57.79M | -19.93M | -97.48M | -61.84M | -30.07M | -4.25M | -5.26M | 3.53M |
Income tax expense | -4K | 24K | -603K | -11K | -152K | -192K | 1.82M | 205K | 139K | 1.28M |
Net income | -163.61M | -128.72M | -57.19M | -19.92M | -97.33M | -61.65M | -30.07M | -4.25M | -5.40M | 3.53M |
Earnings per share | ||||||||||
Basic EPS | -6.08 | -4.57 | -2.08 | -0.73 | -3.6 | -2.5 | -1.52 | -0.23 | -0.38 | 0.01 |
Diluted EPS | -6.08 | -4.57 | -2.08 | -0.73 | -3.6 | -2.5 | -1.52 | -0.23 | -0.36 | 0.01 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |